COVID Vaccines

Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly

Research shows that, unlike tetanus and influenza vaccines, COVID-19 mRNA vaccines do not prompt the generation of durable antibody-producing cells.
Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly
cery/Shutterstock
Marina Zhang
|Updated:
0:00

Research led by scientists at Emory University in Atlanta found that while tetanus and influenza vaccines prompt the body to produce long-lived plasma cells that generate antibodies, COVID-19 vaccines do not.

The study may explain why antibody protection from COVID-19 mRNA vaccines wanes so rapidly.

Marina Zhang
Marina Zhang
Author
Marina Zhang is a health reporter for The Epoch Times. She covers both health news and in-depth features on emerging health issues. Marina holds a bachelor's degree in biomedicine from the University of Melbourne. Contact her at [email protected].
Related Topics